Exploring levels of TSH and FT4 in patients with chronic fatigue syndrome (CFS), fibromyalgia (FM) and healthy controls did not reveal any associations between fatigue score and level of thyroid hormones

References

• Groven N, Fors EA, Stunes AK, et al. MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls. Brain Behav Immun Health. 2020;4:100067. doi: 10.1016/J.BBIH.2020.100067.
   PubMedGoogle Scholar
• Rodriguez-Pintó I, Agmon-Levin N, Howard A, et al. Fibromyalgia and cytokines. Immunol Lett. 2014;161(2):200–203. doi: 10.1016/J.IMLET.2014.01.009.
   PubMed Web of Science ®Google Scholar
• Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005;75:6–21.
   PubMedGoogle Scholar
• Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953–959. doi: 10.7326/0003-4819-121-12-199412150-00009.
   PubMed Web of Science ®Google Scholar
• Linder J, Ekholm KS, Jansen GB, et al. Long-term sick leavers with difficulty in resuming work: comparisons between psychiatric-somatic comorbidity and monodiagnosis. Int J Rehabil Res. 2009;32(1):20–35. doi: 10.1097/MRR.0B013E328306351D.
   PubMed Web of Science ®Google Scholar
• Noor N, Urits I, Degueure A, et al. A comprehensive update of the current understanding of chronic fatigue syndrome. Anesth Pain Med. 2021 11:3, 2021;11(3):e113629. doi: 10.5812/AAPM.113629.
   PubMedGoogle Scholar
• Lim EJ, Ahn YC, Jang ES, et al. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18(1):100. doi: 10.1186/s12967-020-02269-0.
   Web of Science ®Google Scholar
• Groven N, Fors EA, Reitan SK. Patients with fibromyalgia and chronic fatigue syndrome show increased hsCRP compared to healthy controls. Brain Beh′av Immun. 2019;81:172–177. doi: 10.1016/j.bbi.2019.06.010.
   PubMed Web of Science ®Google Scholar
• Sweetman E, Kleffmann T, Edgar C, et al. A SWATH-MS analysis of myalgic encephalomyelitis/chronic fatigue syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. 2020;18(1):365. doi: 10.1186/s12967-020-02533-3.
   PubMed Web of Science ®Google Scholar
• Wirth K, Scheibenbogen C. A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Autoimmun Rev. 2020;19(6):102527. doi: 10.1016/J.AUTREV.2020.102527.
   PubMed Web of Science ®Google Scholar
• Chiovato L, Magri F, Carlé A. Hypothyroidism in context: where we’ve been and where we’re going. Adv Ther. 2019;36(Suppl 2):47–58. doi: 10.1007/S12325-019-01080-8.
   PubMedGoogle Scholar
• Sakai Y, Iversen V, Reitan SK. FT4 and TSH, relation to diagnoses in an unselected psychiatric acute-ward population, and change during acute psychiatric admission. BMC Psychiatry. 2018;18(1):244. doi: 10.1186/s12888-018-1819-3.
   PubMedGoogle Scholar
• Wyller VB, Vitelli V, Sulheim D, et al. Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study. J Transl Med. 2016;14(1):121. doi: 10.1186/s12967-016-0873-1.
   PubMedGoogle Scholar
• Moorkens G, Berwaerts J, Wynants H, et al. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin Endocrinol (Oxf). 2000;53(1):99–106. doi: 10.1046/J.1365-2265.2000.01049.X.
   PubMed Web of Science ®Google Scholar
• Ruiz-Núñez B, Tarasse R, Vogelaar EF, et al. Higher prevalence of “low T3 syndrome” in patients with chronic fatigue syndrome: a case-control study. Front Endocrinol (Lausanne). 2018;9:97. (MAR), doi: 10.3389/FENDO.2018.00097/BIBTEX.
   PubMed Web of Science ®Google Scholar
• Tomic S, Brkic S, Lendak D, et al. Neuroendocrine disorder in chronic fatigue syndrome. Turk J Med Sci. 2017;47(4):1097–1103. doi: 10.3906/SAG-1601-110.
   PubMed Web of Science ®Google Scholar
• Siracusa R, Di Paola R, Cuzzocrea S, et al. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8):3891. doi: 10.3390/IJMS22083891.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–329. doi: 10.1016/J.SEMARTHRIT.2016.08.012.
   PubMed Web of Science ®Google Scholar
• Garrison RL, Breeding PC. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses. 2003;61(2):182–189. doi: 10.1016/s0306-9877(02)00294-3.
   PubMed Web of Science ®Google Scholar
• Aloisi AM, Vodo S, Buonocore M. Pain and thyroid hormones. Neurol Sci. 2013;34(9):1501–1508. doi: 10.1007/S10072-013-1440-7.
   PubMed Web of Science ®Google Scholar
• Jordan B, Uer O, Buchholz T, et al. Physical fatigability and muscle pain in patients with hashimoto thyroiditis. J Neurol. 2021;268(7):2441–2449. doi: 10.1007/S00415-020-10394-5.
   PubMed Web of Science ®Google Scholar
• Ørstavik K, Norheim I, Jørum E. Pain and small-fiber neuropathy in patients with hypothyroidism. Neurology. 2006;67(5):786–791. doi: 10.1212/01.WNL.0000234035.13779.4A.
   PubMed Web of Science ®Google Scholar
• Lowe J, Yellin J, Lowe GH. Female fibromyalgia patients: lower resting metabolic rates than matched healthy controls. Europepmc.Org, 2006. https://europepmc.org/article/med/16810133.
   Google Scholar
• Park S, Kwon JS, Park YB, et al. Is thyroid autoimmunity a predisposing factor for fibromyalgia? A systematic review and meta-analysis. Clin Exp Rheumatol. 2022;40(6):1210–1220. doi: 10.55563/clinexprheumatol/y3gfva.
   PubMed Web of Science ®Google Scholar
• Riedel W, Layka H, Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol. 1998;57 (SUPPL. 2):81–87. doi: 10.1007/S003930050242.
   PubMedGoogle Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum. 1990;33(2):160–172. doi: 10.1002/art.1780330203.
   PubMed Web of Science ®Google Scholar
• Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77. doi: 10.1016/S0022-3999(01)00296-3.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/J.1600-0447.1983.TB09716.X.
   PubMed Web of Science ®Google Scholar
• Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147–153. doi: 10.1016/0022-3999(93)90081-P.
   PubMed Web of Science ®Google Scholar
• Loge JH, Ekeberg Ø, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45(1):53–65. doi: 10.1016/S0022-3999(97)00291-2.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Häuser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med. 2011;43(7):495–502. doi: 10.3109/07853890.2011.595734.
   PubMed Web of Science ®Google Scholar
• Cleeland CS. Pain assesment in cancer. In D. Osoba (Ed.), Effect of cancer on quality of life. Boca Ration: CRC Press; 1991, pp. 293–305.
   Google Scholar
• Klepstad P, Loge JH, Borchgrevink PC, et al. The norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage. 2002;24(5):517–525. doi: 10.1016/S0885-3924(02)00526-2.
   PubMed Web of Science ®Google Scholar
• Suk JH, Lee JH, Kim JM. Association between thyroid autoimmunity and fibromyalgia. Exp Clin Endocrinol Diabetes. 2012;120(7):401–404. doi: 10.1055/s-0032-1309008.
   PubMed Web of Science ®Google Scholar
• Haliloglu S, Ekinci B, Uzkeser H, et al. Fibromyalgia in patients with thyroid autoimmunity: prevalence and relationship with disease activity. Clin Rheumatol. 2017;36(7):1617–1621. doi: 10.1007/S10067-017-3556-2/TABLES/3.
   PubMed Web of Science ®Google Scholar
• Ruíz-Pacheco MG, Hernández I, Hernández-Estrella G, et al. Severity of fatigue and its relationship with TSH before and after levothyroxine replacement therapy in patients with primary hypothyroidism. Biomedicines. 2023;11(3):811. doi: 10.3390/BIOMEDICINES11030811.
   PubMed Web of Science ®Google Scholar
• Tjørve E, Tjørve KMC, Olsen JO, et al. On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med Hypotheses. 2007;69(4):913–921. doi: 10.1016/J.MEHY.2006.12.056.
   PubMed Web of Science ®Google Scholar
• Groven N, Reitan SK, Fors EA, et al. Kynurenine metabolites and ratios differ between chronic fatigue syndrome, fibromyalgia, and healthy controls. Psychoneuroendocrinology. 2021;131:105287. doi: 10.1016/j.psyneuen.2021.105287.
   PubMed Web of Science ®Google Scholar